Prudential Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55M | Buy |
5,130
+453
| +10% | +$137K | ﹤0.01% | 1493 |
|
|
2025
Q1 | $1.55M | Buy |
4,677
+1,022
| +28% | +$339K | ﹤0.01% | 1401 |
|
|
2024
Q4 | $1.13M | Buy |
3,655
+2,282
| +166% | +$704K | ﹤0.01% | 1529 |
|
|
2024
Q3 | $291K | Buy |
1,373
+51
| +4% | +$10.8K | ﹤0.01% | 2405 |
|
|
2024
Q2 | $370K | Buy |
1,322
+203
| +18% | +$56.9K | ﹤0.01% | 2292 |
|
|
2024
Q1 | $299K | Sell |
1,119
-1
| -0.1% | -$267 | ﹤0.01% | 2339 |
|
|
2023
Q4 | $259K | Buy |
+1,120
| New | +$259K | ﹤0.01% | 2366 |
|
|
2023
Q3 | – | Sell |
-1,039
| Closed | -$240K | – | 2660 |
|
|
2023
Q2 | $240K | Sell |
1,039
-5,008
| -83% | -$1.16M | ﹤0.01% | 2375 |
|
|
2023
Q1 | $1.46M | Sell |
6,047
-7,047
| -54% | -$1.71M | ﹤0.01% | 1528 |
|
|
2022
Q4 | $3.8M | Sell |
13,094
-7,755
| -37% | -$2.25M | 0.01% | 988 |
|
|
2022
Q3 | $1.36M | Buy |
20,849
+50
| +0.2% | +$3.25K | ﹤0.01% | 1579 |
|
|
2022
Q2 | $1.49M | Buy |
+20,799
| New | +$1.49M | ﹤0.01% | 1572 |
|
|
2020
Q3 | – | Sell |
-10,894
| Closed | -$1.23M | – | 2456 |
|
|
2020
Q2 | $1.23M | Buy |
10,894
+20
| +0.2% | +$2.27K | ﹤0.01% | 1552 |
|
|
2020
Q1 | $726K | Sell |
10,874
-76
| -0.7% | -$5.07K | ﹤0.01% | 1801 |
|
|
2019
Q4 | $997K | Buy |
+10,950
| New | +$997K | ﹤0.01% | 1857 |
|
|
2018
Q4 | – | Sell |
-1,040
| Closed | -$223K | – | 2422 |
|
|
2018
Q3 | $223K | Buy |
1,040
+210
| +25% | +$45K | ﹤0.01% | 2304 |
|
|
2018
Q2 | $232K | Buy |
+830
| New | +$232K | ﹤0.01% | 2293 |
|